Skip to content

Effects of involuntary breathing movements on central blood flow

Effects of involuntary breathing movements on central blood flow - IBM-Flow

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00028611
Enrollment
25
Registered
2022-03-25
Start date
2025-04-07
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy proband:in

Interventions

Group 1: here will be five breath-hold maneuvers during the study, including the late phase with involuntary breathing movements on MRI. Four repetitions are nornecessary to measure each of the four v

Sponsors

DLR, Deutsches Zentrum für Luft- und Raumfahrt
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age = 18 years Ability to hold breath till onset of IBMs

Exclusion criteria

Exclusion criteria: Pregnancy (will be tested during medical examination) MR Exclusion Criteria o Metal implants or other osteosynthesis material, stents, clips, etc. that are not MRI compatible or interfere with the examination due to their location. o Pacemakers, infusion pumps, neurostimulators, inner ear implants. o Claustrophobia. o Permanent makeup or tattoos that are not suitable for MRI. o Piercings that cannot be removed. Any clinical abnormality on medical examination o Current diseases of vital organs or the central nervous system. o Psychiatric disorders that might prevent subjects from consenting to the examination or complying with the protocol. protocol. o Regular use of medications that could affect the outcome of the study (hormonal contraceptives are not a criterion for exclusion). o Regular consumption of alcohol (20-30 g/day), nicotine (>3 cigarettes/day) or illicit drugs in Germany. o Blood donation within 3 months for women and 2 months for men prior to the study. o Clinically relevant findings in the ECG such as second or third degree AV block, prolongation of the QRS complex over 120 ms or the QTc interval over 450 ms. o Supine hypertension (> 140/90 mmHg) or hypotension (< 90/50 mmHg).

Design outcomes

Primary

MeasureTime frame
Primary endpoint Change in average blood flow in four main vessels (V. cava inferior, Tr. pulmonalis, Aorta ascendens, A. carotis internal) between at least two of the following time points: baseline – early apnea – early IBMs – middle IBMs – late IBMs – recovery. One endpoint for each vessel.

Secondary

MeasureTime frame
Secondary endpoints Change in average blood flow differences during breathing (inspiration – expiration) in the above-mentioned vessels between at least two of the following time points: baseline – early IBMs – middle IBMs – late IBMs – recovery. One endpoint for each vessel. Change in average arterial pressure (mean, systolic, diastolic) between at least two of the following time points: baseline – early apnea – early IBMs – middle IBMs – late IBMs – recovery. One outcome for each measure. Change in average heart rate between at least two of the following time points: baseline – early apnea – early IBMs – middle IBMs – late IBMs – recovery. Change in average peripheral oxygen saturation between at least two of the following time points: baseline – early apnea – early IBMs – middle IBMs – late IBMs – recovery.

Countries

Croatia, Germany

Contacts

Public ContactKarsten Heusser

DLRDeutsches Zentrum für Luft- und Raumfahrt

Karsten.Heusser@dlr.de+49 2203-601-3117

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026